Medicine

All Articles

How to organize the following inevitable Ebola break out: lessons coming from West Africa

.Department of Wellness, Kampala, UgandaHenry Kyobe Bosa, u00c2 Misaki Wayengera, u00c2 Holly G. Mwe...

Perioperative immunotherapy for sac cancer cells

.RESEARCH STUDY HIGHLIGHT.16 October 2024.

In the NIAGARA hearing, the addition of perioperative ...

A chatbot modifies the minds of conspiracy theory thinkers

.RESEARCH STUDY HIGHLIGHT.14 October 2024.

A study of over 2,000 individuals shows that engaging ...

How to create cardiology clinical trials even more inclusive #.\n\nVilcant, V., Ceron, C., Verma, G., Zeltser, R. &amp Makaryus, A. N. Addition of under-represented genetic as well as ethnic groups in cardiovascular medical trials. Heart Bronchi Circ. 31, 1263\u00e2 $\" 1268 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nFilbey, L. et al. Improving representativeness in tests: a call to action coming from the International Cardiovascular Clinical Trialists Forum. Eur. Soul J. 44, 921\u00e2 $\" 930 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nJin, X. et cetera. Women\u00e2 $ s involvement in cardio professional trials from 2010 to 2017. Blood circulation 141, 540\u00e2 $\" 548 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nCholesterol Levels Therapy Trialists\u00e2 $ Cooperation Efficiency and protection of statin treatment in much older individuals: a meta-analysis of private participant records coming from 28 randomised measured trials. Lancet 393, 407\u00e2 $\" 415 (2019 ). Au, M. et al. A step-by-step assessment of sex-specific reporting in cardiac arrest professional tests: trial flow and results. J. Am. Coll. Cardiol. Adv. 1, 100079 (2022 ).\nGoogle Scholar\u00c2.\nWei, S. et cetera. Factors connected with ethnological as well as indigenous variety amongst heart failure test attendees: a step-by-step bibliometric evaluation. Circ. Center Fail. 15, e008685 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nTahhan, A. S. et al. Registration of much older people, girls, as well as racial\/ethnic minority teams in present-day acute coronary syndrome scientific trials: a step-by-step review. JAMA Cardiol. 5, 714\u00e2 $\" 722 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nCherubini, A. et al. The chronic exclusion of much older clients due to continuous scientific trials relating to heart failure. Arc. Intern. Medication. 171, 550\u00e2 $\" 556 (2011 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nMichos, E. D. &amp Vehicle Spall, H. G. C. Enhancing portrayal and diversity in cardio clinical trial populations. Nat. Rev. Cardiol. 18, 537\u00e2 $\" 538 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNational Academies of Sciences, Design, as well as Medicine. Improving Representation in Medical Trials and Investigation: Building Research Equity for Female and also Underrepresented Groups (eds Bibbins-Domingo, K. &amp Helman, A.) (National Academies Bunch, 2022). Packer, M. et al. Cardiovascular and also kidney results along with empagliflozin in heart failure. N. Engl. J. Med. 383, 1413\u00e2 $\" 1424 (2020 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nZannad, F. et cetera. SGLT2 inhibitors in patients with cardiac arrest with minimized ejection fraction: a meta-analysis of the EMPEROR-Reduced and also DAPA-HF tests. Lancet 396, 819\u00e2 $\" 829 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nLam, C. S. P. et al. Regional as well as ethnic effects on the response to empagliflozin in clients with cardiac arrest as well as a lowered ejection fraction: the EMPEROR-Reduced trial. Eur. Soul J. 42, 4442\u00e2 $\" 4451 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nRathore, S. S., Wang, Y. &amp Krumholz, H. M. Sex-based distinctions in the result of digoxin for the treatment of heart failure. N. Engl. J. Med. 347, 1403\u00e2 $\" 1411 (2002 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nMihan, A., Pandey, A. &amp Van Spall, H. G. C. Relieving the risk of artificial intelligence predisposition in heart treatment. Lancet Digit. Health and wellness https:\/\/doi.org\/10.1016\/S2589-7500( 24 )00155-9 (2024 ). Bodicoat, D. H. et al. Marketing introduction in professional trials\u00e2 $\" a swift testimonial of the literature and also suggestions for activity. Tests 22, 880 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nGoldberg, E. M. et al. Using social networks for clinical study: referrals and examples from the Brown-Lifespan Center for Digital Wellness. J. Med. Web Res. 24, e35804 (2022 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nMihan, A. &amp Van Spall, H. G. C. Interventions to enhance electronic health equity in heart care. Nat. Medication. 30, 628\u00e2 $\" 630 (2024 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nFultinavi\u00c4 i\u00c5\" t\u00c4 --, U. AI perks in patient recognition as well as clinical trial employment has difficulties in sight. Medical Tests Field https:\/\/www.clinicaltrialsarena.com\/features\/ai-clinical-trial-recruitment\/ (2022 ). Grover, N. &amp Coulter, M. Understanding: major pharma bank on AI to quicken scientific tests. Wire service https:\/\/www.reuters.com\/technology\/big-pharma-bets-ai-speed-up-clinical-trials-2023-09-22\/ (2023 ). Kretschmer, M., Kretschmer, T., Peukert, A. &amp Peukert, C. The dangers of risk-based AI guideline: taking liability seriously. SSRN https:\/\/doi.org\/10.2139\/ssrn.4622405 (2023 ). Strumberger, S. EU AI Action: the most up to date updates on the world\u00e2 $ s first extensive AI guideline legislations. Thomson Reuters https:\/\/legalsolutions.thomsonreuters.co.uk\/blog\/2023\/12\/12\/ai-act-the-worlds-first-comprehensive-laws-to-regulate-ai\/

:~:text=In%20April%202021%2C%20the%20European,mean%20more%20or%20less%20regulation (2024 ). Ali, M. ...

To control antimicrobial resistance in Africa, construct neighborhood capability

.Boosts in antimicrobial resistance around the globe are likely to hit African nations the hardest. ...

Lessons coming from a negative gene treatment test for Duchenne muscular dystrophy

.Attributes Medication, Posted online: 09 October 2024 doi:10.1038/ s41591-024-03316-9Delandistrogen...

People with heart pacemakers call for multidisciplinary treatment

.Attribute Medicine, Posted online: 09 Oct 2024 doi:10.1038/ s41591-024-03296-wEchocardiographic tes...

AAV genetics treatment for Duchenne muscular dystrophy: the EMBARK period 3 randomized test

.Trial oversightThis test was actually carried out according to the stipulations of the Affirmation ...

Computational human brain models map range ingrained in growing old and also alzheimer's disease

.Publisheru00e2 $ s note Springer Nature remains neutral when it come to managerial cases in publish...

Lassa vaccinations to conserve lives, extra economies and aid in global readiness

.Publisheru00e2 $ s keep in mind Springer Attribute continues to be neutral for managerial cases in ...